Abstract |
The effects of L-ascorbic acid 2-[3,4-dihydro-2,5,7,8-tetramethyl-2- (4,8,12-trimethyltridecyl)-2H-1-benzopyran-6yl-hydrogen phosphate] potassium salt (EPC-K1, CAS 127061-56-7), a new compound for ischemia-reperfusion injuries, on lipid peroxidation and phospholipase A2 activity were studied in vitro using rat brain homogenates and human plasma. EPC-K1 inhibited phospholipase A2 activity in human plasma in a concentration-dependent manner (IC50 = 7.3 x 10(-4) mol/l), whereas a mixture of alpha-tocopherol and ascorbic acid did not exhibit this effect. In rat brain homogenates, EPC-K1 also inhibited lipid peroxidation in a concentration-dependent manner (IC50 = 2.3 x 10(-6) mol/l). alpha-Tocopherol was less active than EPC-K1. These properties of EPC-K1 suggest that EPC-K1 may prove useful in the treatment of ischemia-reperfusion injuries.
|
Authors | Y Kuribayashi, K Yoshida, T Sakaue, A Okumura |
Journal | Arzneimittel-Forschung
(Arzneimittelforschung)
Vol. 42
Issue 9
Pg. 1072-4
(Sep 1992)
ISSN: 0004-4172 [Print] Germany |
PMID | 1445471
(Publication Type: Journal Article)
|
Chemical References |
- Vitamin E
- Phospholipases A
- Phospholipases A2
- Ascorbic Acid
|
Topics |
- Animals
- Ascorbic Acid
(pharmacology)
- Brain
(enzymology)
- Brain Chemistry
(drug effects)
- In Vitro Techniques
- Lipid Peroxidation
(drug effects)
- Male
- Phospholipases A
(antagonists & inhibitors)
- Phospholipases A2
- Rats
- Rats, Wistar
- Vitamin E
(pharmacology)
|